Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BRBR BellRing Brands	$57.58 +0.1%	$63.53	$48.06 ▼ $80.67	$7.30B	0.7	1.39 million shs	832,039 shs
NVST Envista	$20.39 +1.1%	$18.17	$14.22 ▼ $23.00	$3.42B	1	2.50 million shs	1.00 million shs
PEN Penumbra	$250.54 +0.3%	$270.14	$148.00 ▼ $310.00	$9.67B	0.47	453,066 shs	233,847 shs
SOLV Solventum	$77.90 -0.4%	$72.43	$47.16 ▼ $85.92	$13.54B	0.55	1.12 million shs	474,266 shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BRBR BellRing Brands	-2.18%	-2.21%	-8.71%	-22.18%	-2.54%
NVST Envista	+0.93%	+4.18%	+11.55%	+25.38%	+23.54%
PEN Penumbra	-0.66%	-1.50%	-2.74%	-8.57%	+41.79%
SOLV Solventum	+0.44%	+4.38%	+7.02%	+11.12%	+51.57%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BRBR BellRing Brands	3.9944 of 5 stars	4.4	3.0	0.0	2.5	2.5	1.3
NVST Envista	3.7235 of 5 stars	2.2	3.0	3.8	2.6	0.0	1.9
PEN Penumbra	4.7342 of 5 stars	3.4	3.0	3.7	3.4	2.5	1.9
SOLV Solventum	0.9585 of 5 stars	1.1	5.0	0.0	3.4	0.0	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BRBR BellRing Brands	2.81	Moderate Buy	$76.69	33.18% Upside
NVST Envista	2.33	Hold	$20.23	-0.78% Downside
PEN Penumbra	2.88	Moderate Buy	$302.40	20.70% Upside
SOLV Solventum	2.18	Hold	$81.50	4.62% Upside

Current Analyst Ratings Breakdown

Latest NVST, BRBR, SOLV, and PEN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/2/2025	BRBR BellRing Brands	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$65.00 ➝ $60.00
7/1/2025	SOLV Solventum	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$90.00
6/6/2025	SOLV Solventum	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Sector Weight
5/28/2025	BRBR BellRing Brands	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$85.00 ➝ $75.00
5/27/2025	BRBR BellRing Brands	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$85.00
5/27/2025	NVST Envista	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
5/27/2025	NVST Envista	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$21.00 ➝ $23.00
5/19/2025	SOLV Solventum	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$78.00 ➝ $87.00
5/15/2025	BRBR BellRing Brands	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$85.00
5/9/2025	SOLV Solventum	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$80.00 ➝ $78.00
5/8/2025	BRBR BellRing Brands	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$75.00 ➝ $65.00

(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BRBR BellRing Brands	$2.00B	3.66	$2.27 per share	25.36	($1.60) per share	-35.99
NVST Envista	$2.51B	1.38	$1.68 per share	12.14	$17.05 per share	1.20
PEN Penumbra	$1.19B	8.12	$2.90 per share	86.52	$29.99 per share	8.35
SOLV Solventum	$8.25B	1.63	$9.90 per share	7.87	$17.13 per share	4.55

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BRBR BellRing Brands	$246.50M	$2.15	26.78	22.67	1.81	12.82%	-133.63%	32.69%	8/4/2025 (Estimated)
NVST Envista	-$1.12B	-$6.53	N/A	16.85	1.28	-44.90%	4.07%	2.25%	8/6/2025 (Estimated)
PEN Penumbra	$14.01M	$1.06	236.36	50.01	2.23	3.41%	11.14%	8.40%	7/29/2025 (Estimated)
SOLV Solventum	$478M	$2.16	36.06	14.19	2.00	4.55%	31.01%	6.53%	8/4/2025 (Estimated)

Latest NVST, BRBR, SOLV, and PEN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/29/2025	Q2 2025	PEN Penumbra	$0.81	N/A	N/A	N/A	$327.37 million	N/A
5/8/2025	Q1 2025	SOLV Solventum	$1.19	$1.34	+$0.15	$0.78	$2.02 billion	$2.07 billion
5/5/2025	Q2 2025	BRBR BellRing Brands	$0.53	$0.53	N/A	$0.45	$577.56 million	$588.00 million
5/1/2025	Q1 2025	NVST Envista	$0.20	$0.24	+$0.04	$0.10	$608.17 million	$616.90 million
4/23/2025	Q1 2025	PEN Penumbra	$0.66	$0.83	+$0.17	$1.00	$315.72 million	$324.14 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BRBR BellRing Brands	N/A	N/A	N/A	N/A	N/A
NVST Envista	N/A	N/A	N/A	N/A	N/A
PEN Penumbra	N/A	N/A	N/A	N/A	N/A
SOLV Solventum	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BRBR BellRing Brands	N/A	2.92	1.34
NVST Envista	0.43	2.12	1.82
PEN Penumbra	0.02	6.30	3.68
SOLV Solventum	2.40	1.19	0.85

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BRBR BellRing Brands	94.97%
NVST Envista	N/A
PEN Penumbra	88.88%
SOLV Solventum	N/A

Insider Ownership

Company	Insider Ownership
BRBR BellRing Brands	1.07%
NVST Envista	1.30%
PEN Penumbra	4.20%
SOLV Solventum	0.05%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BRBR BellRing Brands	380	127.00 million	125.64 million	Optionable
NVST Envista	12,300	169.49 million	167.28 million	Optionable
PEN Penumbra	4,500	38.73 million	37.10 million	Optionable
SOLV Solventum	22,000	173.01 million	172.93 million	Optionable

NVST, BRBR, SOLV, and PEN Headlines

Recent News About These Companies

First Bank & Trust Purchases Shares of 3,667 Solventum Corporation (NYSE:SOLV)

July 3 at 6:00 AM | marketbeat.com

Argus Upgrades Solventum (NYSE:SOLV) to Buy

July 3 at 2:47 AM | americanbankingnews.com

Argus Research Upgrades Solventum (SOLV)

July 2 at 6:59 AM | msn.com

Solventum (NYSE:SOLV) Raised to "Buy" at Argus

July 1 at 8:25 AM | marketbeat.com

KBC Group NV Increases Position in Solventum Corporation (NYSE:SOLV)

July 1 at 4:58 AM | marketbeat.com

5 Must-Read Analyst Questions From Solventum’s Q1 Earnings Call

June 30 at 12:23 AM | finance.yahoo.com

Solventum Corporation (NYSE:SOLV) Shares Purchased by Sequoia Financial Advisors LLC

June 30 at 3:45 AM | marketbeat.com

Achmea Investment Management B.V. Acquires 4,653 Shares of Solventum Corporation (NYSE:SOLV)

June 29, 2025 | marketbeat.com

Solventum Corporation (NYSE:SOLV) Shares Sold by Trust Co. of Vermont

June 29, 2025 | marketbeat.com

Asset Management One Co. Ltd. Has $4.68 Million Position in Solventum Corporation (NYSE:SOLV)

June 29, 2025 | marketbeat.com

3M Company (MMM) Outpaced Broader Market in 2025 with Renewed Focus on Core Businesses

June 28, 2025 | msn.com

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy - Morningstar

June 27, 2025 | morningstar.comM

Philip James Wealth Mangement LLC Sells 6,884 Shares of Solventum Corporation (NYSE:SOLV)

June 27, 2025 | marketbeat.com

4,697 Shares in Solventum Corporation (NYSE:SOLV) Acquired by Hikari Power Ltd

June 27, 2025 | marketbeat.com

Solventum Corporation (NYSE:SOLV) Shares Sold by Wealth Enhancement Advisory Services LLC

June 27, 2025 | marketbeat.com

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

June 26, 2025 | marketwatch.com

4,030 Shares in Solventum Corporation (NYSE:SOLV) Purchased by Kentucky Retirement Systems Insurance Trust Fund

June 26, 2025 | marketbeat.com

How Is Solventum's Stock Performance Compared to Other Health Care Equipment Stocks?

June 25, 2025 | msn.com

Exchange Traded Concepts LLC Has $78,000 Holdings in Solventum Corporation (NYSE:SOLV)

June 25, 2025 | marketbeat.com

Solventum Corporation (NYSE:SOLV) Stake Decreased by SG Americas Securities LLC

June 25, 2025 | marketbeat.com

Solventum Corporation (NYSE:SOLV) Shares Sold by Johnson Investment Counsel Inc.

June 22, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVST, BRBR, SOLV, and PEN Company Descriptions

BellRing Brands NYSE:BRBR

$57.58 +0.08 (+0.14%)

Closing price 03:30 PM Eastern

Extended Trading

$57.56 -0.02 (-0.04%)

As of 04:20 PM Eastern

BellRing Brands, Inc., together with its subsidiaries, provides various nutrition products in the United States. The company offers ready-to-drink (RTD) protein shakes, other RTD beverages, powders, nutrition bars, and other products primarily under the Premier Protein and Dymatize brands. It distributes its products through club, food, drug, mass, eCommerce, specialty, and convenience channels. BellRing Brands, Inc. was incorporated in 2019 and is headquartered in Saint Louis, Missouri.

Envista NYSE:NVST

$20.39 +0.22 (+1.09%)

Closing price 03:30 PM Eastern

Extended Trading

$20.42 +0.03 (+0.15%)

As of 04:46 PM Eastern

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Penumbra NYSE:PEN

$250.54 +0.80 (+0.32%)

Closing price 03:53 PM Eastern

Extended Trading

$250.54 0.00 (0.00%)

As of 04:08 PM Eastern

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Solventum NYSE:SOLV

$77.90 -0.35 (-0.45%)

Closing price 03:40 PM Eastern

Extended Trading

$77.90 0.00 (0.00%)

As of 04:20 PM Eastern

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time